
	Mr. Joshua T. Brumm, also known as Josh, has been Chief Financial Officer at Versartis, Inc., since December 16, 2013. Mr. Brumm served as the Principal Financial Officer and Principal Accounting Officer of Pharmacyclics Inc. since October 25th 2012. Mr. Brumm served as an Executive Vice President of Finance for Pharmacyclics Inc. since August 14, 2012. He served as the Chief Financial Officer at Zeltiq Aesthetics, Inc. from January 1, 2012 to August 8, 2012 and served as its Principal Accounting Officer until August 8, 2012 having global responsibility for Finance, IT and Administration. Mr. Brumm served as Senior Vice President of Zeltiq Aesthetics, Inc. from May 2012 to August 8, 2012. He served as a Vice President of Corporate Development and Investor Relations at Zeltiq Aesthetics, Inc. since July 2011 and also served as its Vice President, helping take it public in October of 2011. Mr. Brumm served as a Senior Managing Director of International Sales and Corporate Development of Zeltiq Aesthetics, Inc. from March 3, 2011 to July 2011, launching its first commercial product in all markets outside of the United States and Canada. Mr. Brumm served as a Director of International Sales and Corporate Development at Zeltiq Aesthetics, Inc. from June 2010 to January 2011 and as its Director of Corporate Development and Strategy from December 2009 to June 2010. Mr. Brumm served as a Director of Finance at Proteolix, Inc. from March 2009 to December 2009. Mr. Brumm served as Investment Banking Associate as a Member of the West Coast Healthcare Team at Citigroup Global Markets, Inc. He founded of Nu-Ag Distribution, LLC and served as its Chief Executive Officer from December 2002 to June 2007. He served as a Healthcare Investment Banking Analyst for the West Coast Healthcare Team at Morgan Stanley from May 2001 to August 2002. He is an Entrepreneur. Mr. Brumm holds a BA in Business Administration from the University of Notre Dame.
